Overview

Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer

Status:
COMPLETED
Trial end date:
2023-12-22
Target enrollment:
Participant gender:
Summary
Prospective, open label, multi-dose, sequential dose escalation, single-center, Phase 1 trial
Phase:
PHASE1
Details
Lead Sponsor:
GI Biome, Inc.